Sunaina Sinha Haldea, Raymond James Head of Private Capital Advisory, joins 'Closing Bell Overtime' to talk the state of the ...

Fintel reports that on July 14, 2025, Raymond James initiated coverage of Tvardi Therapeutics (NasdaqCM:TVRD) with a Outperform recommendation. Analyst Price Forecast Suggests 80.70% Upside As of June ...

On a broader allocation strategy, Matt Orton said India continues to stand out. In his global equity portfolio, India now ...

Raymond James Finl RJF +0.54% + Free Alerts has outperformed the market over the past 10 years by 3.35% on an annualized basis producing an average annual return of 14.76%. Currently, Raymond James ...

Robert D. Kendall brings decades of experience, including roles at DWS Americas and a former investment unit within Morgan ...

But here's the thing: Despite telling investors Standard Lithium will outperform the stock market, Raymond James valued the ...

The stock's fall snapped a three-day winning streak.

As Raymond James, Wells Fargo and RBC reported big recruiting deals this week, FINRA said it was going to pay back to its ...

See the latest Raymond James Financial Inc stock price (RJF:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

The stock's fall snapped a seven-day winning streak.